MELISSA SIMPSON: Open Payments
NPI 1780826750 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 31 payments from 11 companies in 2025. Trend: 2023 $689 · 2024 $333 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $346 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Madrigal Pharmaceuticals | 1 | $43 |
| Janssen Biotech, Inc. | 2 | $38 |
| Ardelyx, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: RINVOQ, SKYRIZI, LINZESS, REZDIFFRA, CREON, ENTYVIO, TREMFYA, IBSRELA.
Industry payments across GA — which companies pay providers there.
